• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gujarat Themis Biosyn Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Themis
  • BSE Code : 216.0
  • ISIN : INE942C01045
307.00 -6 (-1.76%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    301.35

  • Today’s High

    315.95

  • Open

    310.00

  • Perv Close

    312.50

  • 52W Low

    208.00

  • 52W High

    345.75

Key Indicators

  • P/E(TTM)

    68.74

  • Mar.Cap (₹Cr.)

    3,345.23

  • Div & Yield %

    0.22

  • Book Value(₹)

    22.80

  • Debt-Equity Ratio

    -1.76

  • AGM Date

    30-May-2025

  • EPS

    4.48

  • P/E Ratio

    68.74

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    3,345.23

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.90

  • BV (₹)

    22.80

  • Sales( ₹ in Cr.)

    150.80

  • NP (in Cr.)

    48.77

  • NP Var(%)

    -18.0

  • Div%

    67.0

  • CPS (₹)

    5.00

  • EPS (₹)

    4.50

  • Traded Value (₹ in Lakhs)

    3,355.59

  • 52 Week High

    345.75

  • 52 Week Low

    208.00

  • Price BSE

    308.0

  • Price NSE

    307.00

  • Market Capital( in Cr.)

    3,355.59

  • P/C Ratio

    62.00

  • P/E Ratio

    68.80

  • Price Vs.BV

    4.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 169.82 148.39 114.85 90.56 85.12 41.05
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 169.82 148.39 114.85 90.56 85.12 41.05
Other Income 4.38 6.59 4.05 3.27 1.70 2.21
Stock Adjustments -11.01 3.24 5.13 0.38 4.11 0.00
Total Income 163.19 158.22 124.03 94.21 90.93 43.26
EXPENDITURE :            
Raw Materials 25.67 29.73 21.75 15.75 15.44 1.30
Power and Fuel Cost 26.53 26.41 21.73 16.57 22.86 20.20
Employee Cost 10.21 7.75 7.08 7.11 6.43 5.17
Other Manufacturing Expenses 8.54 6.80 7.91 8.79 10.53 5.29
Selling and Administration Expenses 8.51 6.66 2.31 1.86 1.64 1.39
Miscellaneous Expenses 0.61 0.64 1.15 0.53 0.49 0.35
Employee Benefit Expenses 10.21 7.75 7.08 7.11 6.43 5.17
Less: Preoperative Expenditure -0.01 0.00 0.00 0.00 0.00 0.00
Total Expenses 80.09 77.99 61.94 50.61 57.39 33.68
Operating Profit 83.10 80.22 62.10 43.59 33.54 9.58
Interest 0.23 0.18 0.83 0.98 0.92 0.16
Gross Profit 82.87 80.04 61.27 42.61 32.62 9.42
Depreciation 3.54 2.58 2.23 1.73 1.36 1.22
Profit Before Tax 79.33 77.46 59.04 40.88 31.26 8.20
Current Tax 19.80 19.24 15.34 10.58 7.64 0.87
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.38 0.26 0.07 0.13 -0.05 0.92
Reported Net Profit 59.16 57.97 43.62 30.18 23.67 6.41
Extraordinary Items 0.00 0.00 0.00 0.01 0.62 0.00
Adjusted Net Profit 59.16 57.97 43.62 30.17 23.05 6.41
Adjustment below Net Profit -0.03 0.06 -0.08 -0.03 0.00 0.00
P & L Balance brought forward 139.56 93.74 60.36 32.61 8.93 2.52
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 6.90 12.20 10.17 2.40 0.00 0.00
P & L Balance carried down 191.79 139.56 93.74 60.36 32.61 8.93
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 100.00 108.00 220.00 0.00 33.00 0.00
Dividend Per Share(Rs) 5.00 5.40 11.00 0.00 1.65 0.00
Earnings Per Share-Unit Curr 8.14 39.90 30.03 20.77 16.30 4.41
Earnings Per Share(Adj)-Unit Curr 5.43 5.32 4.00 2.77 2.17 0.59
Book Value 27.72 102.66 71.11 48.14 29.04 12.75
Book Value(Adj)-Unit Curr 18.48 13.69 9.48 6.42 3.87 1.70

Shareholding Pattern

  • Promoter Group

    70.86%

  • Public Share Holding

    29.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 76,512,037 70.22 76,512,037 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 706,046 0.65 706,041 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 77,218,083 70.86 77,218,078 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 750 0.00 750 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 250 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,082,612 1.91 2,082,612 7
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,269,148 1.16 1,255,148 5
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 10,250 0.01 0 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,363,010 3.09 3,338,510 15
2] Non Institution
Bodies Corporate 2,550,893 2.34 2,523,893 148
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,777,298 1.63 1,637,298 791
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,337,831 1.23 1,337,831 460
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,083,281 2.83 3,083,281 9
Individuals holding nominal share capital up to Rs. 1 lakh 18,335,502 16.83 17,333,617 29,209
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,000 0.00 750 2
Others 1,000 0.00 750 2
Sub Total 28,384,172 26.05 27,214,787 30,650
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 108,965,265 100.00 107,771,375 30,673

Company Background

Gujarat Themis Biosyn LtdPharmaceuticals - Indian - Bulk Drugs

  • Gujarat Themis Biosyn Ltd
  • BSE Code : 216.0
  • ISIN : INE942C01045

  • Incorporation Year

    1981

  • Registered Office

    69/C GIDC Industrial Estate
    Valsad Dist, VAPI,
    Gujarat-396195

  • Telephone

    91-260-2430027

  • FAX

    91-260-2400639

  • Chairman

    Dinesh S Patel

  • Managing Director

  • Company Secretary

    RAHUL DWARAKA SONI

  • Auditor

    GMJ & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Gujarat Themis Biosyn Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Novartis India 1,041.65 396.75 335.07 25.49 15.57
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92